Comprehensive studies on the interaction of copper nanoparticles with bovine serum albumin using various spectroscopies.

Copper nanoparticles (NPs) of average size of ~7.5nm were synthesized by chemical reduction method. Fluorescence spectroscopy in synchronous and polarization modes were used to examine the nature of interaction between Cu NPs and bovine serum albumin (BSA) at different temperatures. Fluorescence quenching results suggest that Cu NPs interact with BSA molecule through static mechanism, as inferred from the quenching of BSA fluorophore. The calculated thermodynamic parameters (ΔG°, ΔH°, and ΔS°) hint that the binding process occurs spontaneously by involving hydrophobic forces. Synchronous fluorescence spectra reveal that the interaction of Cu NPs with BSA mostly changes the microenvironment of tryptophan and not of tyrosine residues. The formation of BSA-Cu NPs ground state complex was also confirmed from the resonant light scattering and fluorescence polarization spectra. Circular dichroism and Raman spectra indicate that α-helicity of the BSA decreases due to the interaction with Cu NPs. It was also found that Cu NPs are located in the close proximity of BSA molecule, which transfer energy efficiently from the excited state of BSA fluorophore to the Cu NPs.

[1]  J. Klein Surface interactions with adsorbed macromolecules , 1986 .

[2]  S. Tokonami,et al.  Preparation of Nanogapped Gold Nanoparticle Array for DNA Detection , 2008 .

[3]  Jack F Douglas,et al.  Interaction of gold nanoparticles with common human blood proteins. , 2010, ACS nano.

[4]  N. Chandrasekaran,et al.  Studies on interaction of colloidal Ag nanoparticles with Bovine Serum Albumin (BSA). , 2010, Colloids and surfaces. B, Biointerfaces.

[5]  S. Aștilean,et al.  Study of protein–gold nanoparticle conjugates by fluorescence and surface-enhanced Raman scattering , 2009 .

[6]  Yi Liu,et al.  Fluorescence Study on the Interaction of Bovine Serum Albumin with P-Aminoazobenzene , 2007, Journal of Fluorescence.

[7]  E. B. Hart,et al.  IRON IN NUTRITION V. THE AVAILABILITY OF THE RAT FOR STUDIES IN ANEMIA , 1928 .

[8]  R. Brodersen,et al.  Binding of bilirubin to albumin. , 1980, CRC critical reviews in clinical laboratory sciences.

[9]  T. Sen,et al.  Au Nanoparticle-Based Surface Energy Transfer Probe for Conformational Changes of BSA Protein , 2008 .

[10]  K. Kisich,et al.  The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. , 2005, American journal of respiratory and critical care medicine.

[11]  D. Carter,et al.  Atomic structure and chemistry of human serum albumin , 1992, Nature.

[12]  M. Dang,et al.  Synthesis and optical properties of copper nanoparticles prepared by a chemical reduction method , 2011 .

[13]  E. Bourdon,et al.  The importance of proteins in defense against oxidation. , 2001, Antioxidants & redox signaling.

[14]  Gérald Thouand,et al.  Protein Interactions Investigated by the Raman Spectroscopy for Biosensor Applications , 2012 .

[15]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[16]  M. Bruchez,et al.  Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots , 2003, Nature Biotechnology.

[17]  C. Dugowson,et al.  Nonsteroidal anti-inflammatory drugs. , 2006, Physical medicine and rehabilitation clinics of North America.

[18]  P. Chakrabarti,et al.  Binding of chloroquine-conjugated gold nanoparticles with bovine serum albumin. , 2011, Journal of colloid and interface science.

[19]  Douglas S. Clark,et al.  Esterase activity of bovine serum albumin up to 160 °C: A new benchmark for biocatalysis , 2008 .

[20]  D. Kothari,et al.  Study of Interaction of Silver Nanoparticles with Bovine Serum Albumin Using Fluorescence Spectroscopy , 2011, Journal of Fluorescence.

[21]  A. Sułkowska,et al.  Interaction of drugs with bovine and human serum albumin , 2002 .

[22]  W. Norde,et al.  Why proteins prefer interfaces. , 1991, Journal of biomaterials science. Polymer edition.

[23]  Ming Zhao,et al.  Novel Cu(II)-RGD-octapeptides: Synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structure. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[24]  S. Serin,et al.  Antimicrobial activity studies of mononuclear and binuclear mixed-ligand copper(II) complexes derived from Schiff base ligands and 1,10-phenanthroline , 1999 .

[25]  C. Werner,et al.  Adsorption-induced conformational changes of proteins onto ceramic particles: differential scanning calorimetry and FTIR analysis. , 2006, Journal of colloid and interface science.

[26]  M. Eftink,et al.  Fluorescence quenching studies with proteins. , 1981, Analytical biochemistry.

[27]  I. Nabiev,et al.  Molecular interaction of proteins and peptides with nanoparticles. , 2012, ACS nano.

[28]  S. Arunachalam,et al.  BSA binding and antimicrobial studies of branched polyethyleneimine-copper(II)bipyridine/phenanthroline complexes. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[29]  David D. Christ,et al.  Chapter 33. Plasma Protein Binding of Drugs , 1996 .

[30]  M. Ashokkumar,et al.  The interaction of sonochemically synthesized gold nanoparticles with serum albumins. , 2010, Journal of pharmaceutical and biomedical analysis.

[31]  M. Refat,et al.  Spectroscopic characterizations and biological studies on newly synthesized Cu(2+) and Zn(2+) complexes of first and second generation dendrimers. , 2009, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[32]  M. Guo,et al.  Analysis of the spectroscopic characteristics on the binding interaction between tosufloxacin and bovine lactoferrin , 2011 .

[33]  Kenneth A. Dawson,et al.  Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.

[34]  Paweł Szymański,et al.  Development of copper based drugs, radiopharmaceuticals and medical materials , 2012, BioMetals.

[35]  A. Dasgupta,et al.  Interaction of hemoglobin and copper nanoparticles: implications in hemoglobinopathy. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[36]  M. Otagiri,et al.  Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. , 2002, Biological & pharmaceutical bulletin.

[37]  A. Torreggiani,et al.  Use of Raman spectroscopy for the identification of radical-mediated damages in human serum albumin , 2011, Analytical and bioanalytical chemistry.

[38]  D. Kothari,et al.  Systematic investigation on the interaction of bovine serum albumin with ZnO nanoparticles using fluorescence spectroscopy. , 2013, Colloids and surfaces. B, Biointerfaces.

[39]  D. Leslie-Pelecky,et al.  Iron oxide nanoparticles for sustained delivery of anticancer agents. , 2005, Molecular pharmaceutics.

[40]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.